All terms in EFO
| Label | Id | Description |
|---|---|---|
| Brachydactyly - elbow wrist dysplasia | Orphanet_1275 | |
| obsolete_fine-Lubinsky syndrome | Orphanet_1272 | |
| height growth measurement | EFO_0005201 | [growth is measured as the difference in body height between two time points] |
| sulfate measurement | EFO_0007864 | [Quantification of the amount of sulfate, an inorganic polyatomic anion, in a sample. Sulfate is critical in many organisms in the biotransformation of multiple compounds via sulfotransferase-mediated sulfate conjugation (sulfation).] |
| tyrosine-protein kinase LYN, isoform b measurement | EFO_0020828 | [The determination of the amount of tyrosine-protein kinase LYN, isoform b in a sample] |
| illness severity status | EFO_0007863 | [quantification of the severity of a patient's illness, eg critical or mild] |
| response to hydrochlorothiazide | EFO_0005202 | [Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hydrochlorothiazide stimulus. ] |
| response to thiazide | EFO_0007981 | [Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a thiazide stimulus. Thiazides are a class of diuretics used primarily to treat hypertension and edema.] |
| tyrosine-protein kinase receptor TYRO3 measurement | EFO_0020829 | [The determination of the amount of tyrosine-protein kinase receptor TYRO3 in a sample] |
| obsolete_Bowen-Conradi syndrome | Orphanet_1270 | [Bowen-Conradi syndrome (BCS) is a lethal autosomal recessive ribosomal biogenesis disorder characterized by severe prenatal and postnatal growth retardation, macrocephaly, a distinctive facial appearance, extreme psychomotor delay, hip and knee contractures and rockerbottom feet.] |
| antiphospholipid antibody measurement | EFO_0005200 | [Quantification of antiphospholipid antibodies in a biological sample, usually a blood sample. Antiphospholipid antibodies include anticardiolipin antibodies (ACL), lupus anticoagulant (LAC), and anti- β 2 glycoprotein I antibodies (anti- β 2GPI).They can be an indicator of antiphospholipid syndrome] |
| response to dabigatran etexilate | EFO_0005205 | [Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of treatment with dabigatran etexilate, an anticoagulant from the class of direct thrombin inhibitors. Dabigatran is used to prevent strokes in patients with atrial fibrillations due to causes other than heart valve disease, and at least one additional risk factor for stroke,and to prevent the formation of blood clots in the veins in adults who have had an operation to replace a hip or knee.] |
| response to erlotinib | EFO_0007868 | [Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an erlotinib stimulus.] |
| erlotinib | CHEBI_114785 | [A quinazoline compound having a (3-ethynylphenyl)amino group at the 4-position and two 2-methoxyethoxy groups at the 6- and 7-positions.] |
| tyrosine-protein kinase HCK measurement | EFO_0020824 | [The determination of the amount of tyrosine-protein kinase HCK in a sample] |
| response to gefitinib | EFO_0007867 | [Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a gefitinib stimulus.] |
| oligoclonal band measurement | EFO_0005206 | [detection or quantification of bands of immunoglobulins in blood serum or cerebrospinal fluid, usually as an indicator of central nervous system disorders such as multiple sclerosis, Lyme disease, systemic lupus erythematosus or neurosarcoidosis] |
| tyrosine-protein kinase JAK2 measurement | EFO_0020825 | [The determination of the amount of tyrosine-protein kinase JAK2 in a sample] |
| response to rifampicin | EFO_0007866 | [Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus with rifampicin, an antibiotic used to fight several types of bacterial infections, including tuberculosis, leprosy and Legionnaire's disease] |
| tyrosine-protein kinase LCK measurement | EFO_0020826 | [The determination of the amount of tyrosine-protein kinase LCK in a sample] |